BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) was the recipient of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 251,200 shares, an increase of 175.1% from the October 31st total of 91,300 shares. Based on an average daily volume of 367,200 shares, the days-to-cover ratio is presently 0.7 days.
Insider Transactions at BlackRock Capital Allocation Term Trust
In other news, major shareholder Saba Capital Management, L.P. sold 14,973 shares of the firm’s stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $16.41, for a total value of $245,706.93. Following the completion of the transaction, the insider now directly owns 16,302,733 shares in the company, valued at $267,527,848.53. This trade represents a 0.09 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders sold a total of 723,927 shares of company stock worth $11,925,047 over the last three months.
Institutional Trading of BlackRock Capital Allocation Term Trust
Several hedge funds and other institutional investors have recently bought and sold shares of BCAT. Transcend Capital Advisors LLC grew its holdings in BlackRock Capital Allocation Term Trust by 7.3% during the second quarter. Transcend Capital Advisors LLC now owns 65,207 shares of the company’s stock worth $1,070,000 after acquiring an additional 4,435 shares during the period. Cambridge Investment Research Advisors Inc. grew its holdings in BlackRock Capital Allocation Term Trust by 4.3% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 133,238 shares of the company’s stock worth $2,186,000 after acquiring an additional 5,438 shares during the period. Blue Bell Private Wealth Management LLC grew its holdings in BlackRock Capital Allocation Term Trust by 4.0% during the second quarter. Blue Bell Private Wealth Management LLC now owns 104,722 shares of the company’s stock worth $1,718,000 after acquiring an additional 4,059 shares during the period. Prevail Innovative Wealth Advisors LLC acquired a new stake in BlackRock Capital Allocation Term Trust during the second quarter worth about $1,452,000. Finally, Almitas Capital LLC acquired a new stake in BlackRock Capital Allocation Term Trust during the second quarter worth about $728,000. 36.12% of the stock is owned by institutional investors and hedge funds.
BlackRock Capital Allocation Term Trust Stock Performance
BlackRock Capital Allocation Term Trust Increases Dividend
The business also recently announced a monthly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be issued a dividend of $0.2885 per share. This represents a $3.46 annualized dividend and a yield of 21.40%. This is a positive change from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10. The ex-dividend date is Friday, November 15th.
About BlackRock Capital Allocation Term Trust
–
Further Reading
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- What is Forex and How Does it Work?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What to Know About Investing in Penny Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.